×
P3 Health Partners EBIT 2020-2025 | PIII
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
P3 Health Partners ebit from 2020 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
P3 Health Partners EBIT 2020-2025 | PIII
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
P3 Health Partners ebit from 2020 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$46.1B
Hims & Hers Health (HIMS)
$11.6B
Doximity (DOCS)
$11.6B
Tempus AI (TEM)
$10B
IRhythm Technologies (IRTC)
$4.4B
Inspire Medical Systems (INSP)
$3.8B
Hinge Health (HNGE)
$3.7B
Privia Health (PRVA)
$2.5B
Enovis (ENOV)
$1.8B
Phreesia (PHR)
$1.6B
Schrodinger (SDGR)
$1.6B
10x Genomics (TXG)
$1.5B
Clover Health Investments (CLOV)
$1.5B
Azenta (AZTA)
$1.5B
Evolent Health (EVH)
$1.3B
Omnicell (OMCL)
$1.3B
Claritev (CTEV)
$763M
Fulgent Genetics (FLGT)
$582M
Veradigm (MDRX)
$547M
Standard BioTools (LAB)
$475M
Butterfly Network (BFLY)
$450M
Talkspace (TALK)
$430M
Outset Medical (OM)
$333M
TruBridge (TBRG)
$329M
Health Catalyst (HCAT)
$269M
Nyxoah SA (NYXH)
$267M
SOPHiA GENETICS SA (SOPH)
$231M
CapsoVision (CV)
$203M
KORU Medical Systems (KRMD)
$149M
Zepp Health (ZEPP)
$139M